Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates
In melanoma patients, CD8+ cytotoxic T cells have been found recognizing self-proteins of which the expression is restricted to the melanocytic lineage. These melanocyte differentiation antigens are expressed in normal melanocytes as well as in 80-100% of primary and metastatic melanoma. In this rep...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Article (Journal) |
| Lenguaje: | inglés |
| Publicado: |
03 March 2004
|
| In: |
Cancer immunology immunotherapy
Year: 2004, Volumen: 53, Número: 8, Pages: 715-722 |
| ISSN: | 1432-0851 |
| DOI: | 10.1007/s00262-004-0514-z |
| Acceso en línea: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00262-004-0514-z
|
| Notas de Autor: | Marieke Griffioen, Martina Borghi, Peter I. Schrier, Susanne Osanto, Dirk Schadendorf |
| Sumario: | In melanoma patients, CD8+ cytotoxic T cells have been found recognizing self-proteins of which the expression is restricted to the melanocytic lineage. These melanocyte differentiation antigens are expressed in normal melanocytes as well as in 80-100% of primary and metastatic melanoma. In this report, six HLA-A*0201-subtyped metastatic melanoma patients vaccinated with dendritic cells (DCs) pulsed with autologous tumor lysates and keyhole limpet hemocyanin (KLH) were screened for the presence of CD8+ T cells specific for three HLA-A*0201-binding peptides derived from the melanosomal antigens MART-1/Melan-A, gp100, and tyrosinase. For this purpose, nonstimulated as well as in vitro peptide-stimulated peripheral blood mononuclear cells (PBMCs) were tested for peptide-specific IFN-γ release by enzyme-linked immunosorbent spot (ELISpot) assays. Furthermore, expression of the melanosomal antigens MART-1/Melan-A, gp100, and tyrosinase in tumor lesions was analyzed by immunohistochemistry before and after vaccination. We also used the ELISpot technique to investigate whether KLH-specific T cells were induced and whether these cells released type 1 (IFN-γ) and/or type 2 (IL-13) cytokines. Our data show induction of CD8+ T cells specific for the melanosomal peptides MART-1/Melan-A27-35 or tyrosinase1-9, as well as IFN-γ-releasing KLH-specific T cells, in two of six vaccinated melanoma patients, but do not support an association between the induction of these T cells and clinical responses. |
|---|---|
| Notas: | Gesehen am 25.11.2020 |
| Descripción Física: | Online Resource |
| ISSN: | 1432-0851 |
| DOI: | 10.1007/s00262-004-0514-z |